This article first appeared in the December issue of AAOS Now, the monthly news magazine of the American Academy of Orthopaedic Surgeons (AAOS).
A study that sought to determine what factors predict total joint arthroplasty (TJA) outcomes at one year found that among patients in the American Joint Replacement Registry (AJRR) for whom patient-reported outcome measures (PROMs) had been recorded, preoperative PROMs, especially physical function subscores, predicted improvement at one year.
Among the 8,031 total knee arthroplasty (TKA) patients, 88 percent reached MCID, and 70 percent reached SCB. There were 507 linked revision surgeries (6.3 percent). Predictors of success were female sex, younger age, medium hospital size, higher mental health score, and lower physical function. Predictors of revision surgery were younger age, decreased PROMIS mental health, and larger hospital size. Unlike with hips, no effect was found to be associated with teaching institution.
Lead study author Chancellor F. Gray, MD, FAAOS, of the University of Florida College of Medicine, said an overall revealing finding of the study was that “AJRR contains about 70,000 procedures with linked preoperative PROMs—which is a pretty remarkable number, though it still represents a large opportunity.” Summarizing the noteworthy conclusions, he said: “THAs outperform TKAs in terms of patient improvement: 93 percent of THA patients reach MCID, while about 88 percent of TKA patients do. Women are substantially more likely than men to reach clinical benefit with both procedures, and younger patients generally were more likely to see statistical improvement than older ones. Medium-sized hospitals also outperformed smaller and larger hospitals.” Among both groups, he noted, revision surgery was more likely when performed in a large hospital (defined as > 400 beds).
Dr. Gray said he and his colleagues were prompted to conduct the study because “we had been developing interest in the relationship between PROMs and surgical outcomes—both pre- and postoperative PROMs: In what way could a PROM be another valuable piece of clinical information to help guide management of patients? Could PROM data help us predict treatment failures, especially revisions? We also knew that AJRR contained incredible amounts of data on other patient and hospital characteristics and wanted to leverage the large dataset to help us better understand if there were any other patient or hospital characteristics that might help us predict lower-extremity arthroplasty outcomes.”
Takeaways and a Surprise
He said one finding came as a surprise: “Both female sex and younger age made such a difference in outcome across the board. Women seem to be much more likely than equivalent male counterparts to see a substantial improvement after both THA and TKA.”
Among the primary clinical takeaways: “Preoperatively, patients with higher mental health and lower physical function are more likely to experience clinical benefit with lower-extremity arthroplasty. In fact, for TKA patients, poor preoperative mental health score was actually linked to increased likelihood of early revision surgery.”
He said the study demonstrates both the value of the AJRR and the data it currently contains, as well as the greater potential of AJRR and other registries. He noted that although AJRR contains 70,000 surgeries with linked PROMs, “that still represents a huge potential opportunity for improved capture—the majority of procedures in AJRR do not contain this valuable data. As that data capture improves, similar studies in the future will be even more powerful. AJRR, in the future, will be a powerful tool to help predict individual patient risk for clinical improvement and risk for revision surgery.”
Dr. Gray he and his colleagues “also think AJRR can help risk-adjust surgical practices—for instance, surgeons whose practice primarily involved operating in a large hospital on older men should be expected to have less patients who meet MCID. That’s important if we eventually link reimbursement to PROMs.”
In terms of further areas of exploration that the study raised, Dr. Gray said, “Even with relatively small numbers, we did find linkage between certain patient factors and revision surgery. We will ultimately need a deeper understanding of that relationship—either through better capture of linked revisions over a longer time frame or continued improvement in capture of pre- and postoperative PROMs.”
Limitations of the study, he said, “reflect traditional problems with large databases: We rely on good data input by the individual contributing institutions, and, at this level, it is hard to tease out some of the subtleties that may make application of these findings more tailorable to specific patients. We also had the best data for linked revision surgeries for Medicare patients, so there may be many revisions that we failed to capture because they were performed at non-AJRR reporting hospitals or fell just outside our time window.”
Dr. Gray’s coauthors of “Leveraging Patient-reported Outcome Measures from the American Joint Replacement Registry to Predict Total Joint Arthroplasty Patient Outcomes at One Year” are Prakash Jayakumar, MD, PhD; Paul A. Rizk, MD; James I. Huddleston III, MD, FAAOS; Kevin J. Bozic, MD, MBA; and Hari K. Parvataneni, MD.
Information about obtaining access to AAHKS Annual Meeting content may be found at aahks.org.
Terry Stanton is the senior medical writer for AAOS Now. He can be reached at firstname.lastname@example.org.
Be sure to leave a comment in the form below!